(Q33715241)

28 July 2017

1 reference

title

Pharmacologic stress echocardiography. Dobutamine and arbutamine stress testing (English)

1 reference

28 July 2017

1 reference

Orsinelli DA

1

1 reference

PubMed ID

10453293

28 July 2017

Daniels CJ

series ordinal

2

1 reference

PubMed ID

10453293

28 July 2017

language of work or name

1 reference

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

17

1 reference

28 July 2017

3

1 reference

28 July 2017

461-79, viii

1 reference

Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Complementary value of two-dimensional exercise echocardiography to routine treadmill exercise testing

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography. Stressing the indications for preoperative testing

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Safety and efficacy of closed-loop arbutamine stress echocardiography for detection of coronary artery disease. International Arbutamine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Central and peripheral adrenergic receptor agonists in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Usefulness of isometric exercise during dobutamine administration for stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine digital echocardiography for detecting coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress test to diagnose the presence and severity of coronary artery lesions in angina

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Echocardiographic criteria to distinguish reversible from irreversible myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Safety of dobutamine stress echocardiography in patients with left ventricular apical thrombus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Cardiac rupture with dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncar

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Predictive value of dobutamine echocardiography just before noncardiac vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Impaired systolic blood pressure response to dobutamine stress testing: a marker of more severe functional abnormalities in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Prognostic implications of a normal dobutamine-atropine stress echocardiogram in patients with chest pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Early chronotropic incompetence predicts the need for atropine during dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Recognition of the segmental tendency of false-positive dobutamine stress echocardiograms and its effects on test sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Drugs five years later. Dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Reduced test time by early identification of patients requiring atropine during dobutamine stress echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

The dobutamine stress test as an alternative to exercise testing after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography for detection and assessment of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography before and after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Relation between dynamic midventricular obstruction and unexplained chest pain in patients with normal echocardiograms at rest

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Stress echocardiography. From pathophysiological toy to diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

In vivo analysis of adrenergic receptor activity of dobutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Echocardiographic detection of coronary artery disease during dobutamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Applications of stress echocardiography: beyond coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Optimal stage duration in dobutamine stress echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

Effects of prolonging peak dobutamine dose during stress echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970091-6

7 January 2021

10.1016/S0733-8651(05)70091-6

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10453293